NO20040203L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20040203L
NO20040203L NO20040203A NO20040203A NO20040203L NO 20040203 L NO20040203 L NO 20040203L NO 20040203 A NO20040203 A NO 20040203A NO 20040203 A NO20040203 A NO 20040203A NO 20040203 L NO20040203 L NO 20040203L
Authority
NO
Norway
Prior art keywords
formula
chemical connections
corticotropin
crf
prodrugs
Prior art date
Application number
NO20040203A
Other languages
English (en)
Inventor
Yves St-Denis
Romano Di Fabio
Collin F Regan
Michael K Schwaebe
Fabrizio Micheli
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of NO20040203L publication Critical patent/NO20040203L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
NO20040203A 2001-07-17 2004-01-16 Kjemiske forbindelser NO20040203L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117395.4A GB0117395D0 (en) 2001-07-17 2001-07-17 Chemical compounds
PCT/US2002/022394 WO2003008414A1 (en) 2001-07-17 2002-07-15 Chemical compounds

Publications (1)

Publication Number Publication Date
NO20040203L true NO20040203L (no) 2004-03-16

Family

ID=9918654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040203A NO20040203L (no) 2001-07-17 2004-01-16 Kjemiske forbindelser

Country Status (20)

Country Link
EP (1) EP1425281B1 (no)
JP (1) JP2004537555A (no)
KR (1) KR20040027880A (no)
CN (1) CN1541217A (no)
AT (1) ATE316972T1 (no)
AU (1) AU2002354916B2 (no)
BR (1) BR0211220A (no)
CA (1) CA2452009A1 (no)
DE (1) DE60209014T2 (no)
ES (1) ES2256506T3 (no)
GB (1) GB0117395D0 (no)
HU (1) HUP0400460A2 (no)
IL (1) IL159521A0 (no)
MX (1) MXPA04000492A (no)
NO (1) NO20040203L (no)
NZ (1) NZ530508A (no)
PL (1) PL367965A1 (no)
RU (1) RU2004104464A (no)
WO (1) WO2003008414A1 (no)
ZA (1) ZA200309942B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1512883A (zh) 2001-04-30 2004-07-14 Crf受体拮抗剂
CA2450535A1 (en) 2001-05-21 2002-11-28 Neurocrine Biosciences Inc. Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
EP2002836B1 (en) * 2007-05-31 2010-10-20 Nerviano Medical Sciences S.r.l. Cyclocondensed azaindoles active as kinase inhibitors
DK2440558T3 (en) 2009-06-08 2015-07-06 Takeda Pharmaceutical Dihydropyrrolnaphthyridinon-relations as inhibitors of jak
RU2498986C2 (ru) * 2011-07-20 2013-11-20 Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран) ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
CN106279011A (zh) * 2016-08-16 2017-01-04 成都百事兴科技实业有限公司 一种2,4‑二羟基‑6‑甲基烟酸乙酯的制备方法
KR102462991B1 (ko) * 2020-11-02 2022-11-04 한국해양과학기술원 남극-유래 진균 균주 아크레모늄(Acremonium sp.) SF-7394에서 분리한 화합물 및 이를 포함하는 항염증, 항암 또는 항당뇨용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605642A (en) * 1984-02-23 1986-08-12 The Salk Institute For Biological Studies CRF antagonists
NZ511267A (en) * 1998-11-12 2002-12-20 Neurocrine Biosciences Inc Tricyclic heterocyclic CRF receptor antagonists and their use in treatment
IL142893A0 (en) * 1998-11-12 2002-04-21 Neurocrine Biosciences Inc Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
GB0117395D0 (en) 2001-09-05
PL367965A1 (en) 2005-03-07
ES2256506T3 (es) 2006-07-16
KR20040027880A (ko) 2004-04-01
ZA200309942B (en) 2004-05-25
AU2002354916B2 (en) 2006-10-19
RU2004104464A (ru) 2005-08-10
BR0211220A (pt) 2004-07-13
JP2004537555A (ja) 2004-12-16
HUP0400460A2 (hu) 2005-01-28
DE60209014T2 (de) 2006-07-13
EP1425281B1 (en) 2006-02-01
EP1425281A1 (en) 2004-06-09
IL159521A0 (en) 2004-06-01
DE60209014D1 (de) 2006-04-13
NZ530508A (en) 2005-11-25
MXPA04000492A (es) 2005-03-07
ATE316972T1 (de) 2006-02-15
CA2452009A1 (en) 2003-01-30
WO2003008414A1 (en) 2003-01-30
CN1541217A (zh) 2004-10-27

Similar Documents

Publication Publication Date Title
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
NO20035583D0 (no) Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner
UY27431A1 (es) Compuestos químicos
UY27435A1 (es) Compuestos químicos
NO20032829D0 (no) Kjemiske forbindelser
GB0121621D0 (en) Chemical compounds
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
TW200602036A (en) Diphenylazetidone derivates
SE0200920D0 (sv) Novel compounds
NO20082496L (no) Pyrazinderivater
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
MXPA04000814A (es) Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo.
MXPA05012247A (es) Derivados de bencimidazol nuevos.
DE602004005960D1 (de) Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
SE0302139D0 (sv) Novel compounds
ATE300541T1 (de) Pyrazolopyridinderivate
NO20040206L (no) Kjemiske forbindelser
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
NO20040203L (no) Kjemiske forbindelser
SE0303280D0 (sv) Novel compounds
ATE274515T1 (de) Pyrazolopyridinderivate
DE60226971D1 (de) Corticotropinfreisetzungsfaktor antagonisten
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
SE9904128D0 (sv) Novel compounds